Prognostic Value of Procalcitonin for Morbidity and Mortality in Patients after Cardiac Surgery

Table 3

Comparison of the outcomes under scrutiny during a one-year follow-up period based on serum PCT levels and previous diseases.

Variable	Serum PCT level ≤0.8		value	Serum PCT level >0.8		value
	With diabetes, N (%)	Without diabetes, N (%)		With diabetes, N (%)	Without diabetes, N (%)
Dysrhythmia			—			0.765
Yes	0 (0.0)	0 (0.0)		4 (11.4)	10 (16.1)
No	1 (100.0)	2 (100.0)		31 (88.6)	52 (83.9)
CVA			—			1.000
Yes	0 (0.0)	0 (0.0)		1 (2.9)	3 (4.8)
No	1 (100.0)	2 (100.0)		34 (97.1)	59 (95.2)
Death			—			0.277
Yes	0 (0.0)	0 (0.0)		5 (14.3)	4 (6.5)
No	1 (100.0)	2 (100.0)		30 (85.7)	58 (93.5)
Wound infection			—			0.257
Yes	0 (0.0)	0 (0.0)		8 (22.9)	8 (12.9)
No	1 (100.0)	2 (100.0)		27 (77.1)	54 (87.1)
Variable	With hypertension, N (%)	Without hypertension, N (%)	value	With hypertension, N (%)	Without hypertension, N (%)	value
Dysrhythmia			—			0.569
Yes	0 (0.0)	0 (0.0)		7 (12.5)	7 (17.1)
No	1 (100.0)	2 (100.0)		49 (87.5)	34 (82.9)
CVA			—			1.000
Yes	0 (0.0)	0 (0.0)		2 (3.6)	2 (4.9)
No	1 (100.0)	2 (100.0)		54 (96.4)	39 (95.1)
Death			—			0.009
Yes	0 (0.0)	0 (0.0)		9 (16.1)	0 (0.0)
No	1 (100.0)	2 (100.0)		47 (83.9)	41 (100.0)
Wound infection			—			0.583
Yes	0 (0.0)	0 (0.0)		8 (14.3)	8 (19.5)
No	1 (100.0)	2 (100.0)		48 (85.7)	33 (80.5)
Variable	With dyslipidemia, N (%)	Without dyslipidemia, N (%)	value	With dyslipidemia, N (%)	Without dyslipidemia, N (%)	value
Dysrhythmia			—			0.018
Yes	0 (0.0)	0 (0.0)		2 (4.5)	12 (22.6)
No	1 (100.0)	2 (100.0)		42 (95.5)	41 (77.4)
CVA			—			0.624
Yes	0 (0.0)	0 (0.0)		1 (2.3)	3 (5.7)
No	1 (100.0)	2 (100.0)		43 (97.7)	50 (94.3)
Death			—			0.001
Yes	0 (0.0)	0 (0.0)		9 (20.5)	0 (0.0)
No	1 (100.0)	2 (100.0)		35 (79.5)	53 (100.0)
Wound infection			—			0.276
Yes	0 (0.0)	0 (0.0)		5 (11.4)	11 (20.8)
No	1 (100.0)	2 (100.0)		39 (88.6)	42 (79.2)